Home LiteratureArticle Details
PMID: 2961059 Published · ppublish English Journal Article

YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation.

Science (New York, N.Y.) ·Vol. 238 ·No. 4830 ·1987-11-20 ·Pages 1132-4

Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, Martin GR

Abstract

The invasion of tumor cells through basement membranes is a critical step in the formation of metastases. The binding of the malignant cells to laminin in the basement membranes allows their attachment and activates their invasiveness. Recently a synthetic nonapeptide from the B1 chain sequence of laminin was identified as a major site for cell binding. A pentapeptide within the nonapeptide sequence was found to reduce the formation of lung colonies in mice injected with melanoma cells and also to inhibit the invasiveness of the cells in vitro.

MeSH Terms
Animals Basement Membrane/physiopathology Binding Sites Cell Adhesion/drug effects Laminin Lung Neoplasms/secondary Melanoma, Experimental/pathology,physiopathology Mice Neoplasm Metastasis/prevention & control Oligopeptides/chemical synthesis,pharmacology Receptors, Immunologic/drug effects Receptors, Laminin Structure-Activity Relationship
Chemicals
Laminin Oligopeptides Receptors, Immunologic Receptors, Laminin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Iwamoto Y
Laboratory of Developmental Biology and Anomalies, National Institute of Drug Research, Bethesda, MD 20892.
Robey F A
Graf J
Sasaki M
Kleinman H K
Yamada Y
Martin G R
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1987-11-20
Pages
1132-4
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com